Seminar 6 – Medtech Manufacturing Series Wrap-Up: Shaping the Future
May 8 @ 4:00 pm - 6:45 pm AEST
Event Navigation
Medtech Manufacturing Series
In partnership with the Australian Medtech Manufacturing Centre (AMMC), BioMelbourne Network is excited to deliver a six-part seminar series for the Victorian medtech manufacturing sector.
Victorian medtech manufacturers produce cutting-edge, high-quality products and have the capability and ambition to scale, backed by a strong R&D ecosystem. Through a series of keynote presentations, panel discussions and networking functions, the series will showcase local success stories, highlight the capabilities of Victoria-based manufacturers and explore the impact on the local economy.
By providing access to industry experts, networks, and resources, the series aims to strengthen the growth and development of the local medtech sector, helping to bring new innovations to market and drive the future economic growth of Victoria.
Seminar Six – Medtech Manufacturing Series Wrap-Up: Shaping the Future
Join us for the grand finale of the Medtech Manufacturing Series, a dynamic conversation about sovereign manufacturing, innovation trends now, in the next five to ten years, and the long-term consequences for our sector. Discover what success looks like for start-ups engaging in this space, how AI and machine learning are impacting productivity and the workforce, and opportunities for global companies to manufacture here. Our speakers will also discuss partnerships and advocating for the sector’s growth and sustainability.
Be informed about:
- The state of play – Key achievements, challenges and opportunities
- Innovation success stories – Technologies and advancements
- The future – Top innovation trends for 2024 and beyond
- Making it happen – Advocacy, support and collaboration.
What to expect:
- The latest updates from industry experts
- Engaging information for diverse audiences
- Dynamic panel Q&A session
- In-person networking opportunities with peers.
Who should attend?
- Professionals seeking to improve knowledge and foster connections in the medtech manufacturing space
- SMEs, start-ups and industry service providers developing, designing and/or manufacturing products for market
- CEOs, CSOs, CTOs, procurement leads, product designers, engineers, scientists and researchers
- Clinicians and policy makers.
Seminar Six details:
Date: Wednesday 8 May 2024
Time (AEST):
3:45 pm: Guest arrival and registration
4:00 pm – 5:45 pm: Presentations and Q&A
5:45 pm – 6:45 pm: Networking
Format: Hybrid – In person and live-streamed
Venue: Science Gallery Melbourne Theatre, 114 Grattan St, Carlton VIC 3053
Facilitator: Dr Ewa Douroux, Marketing Director Asia Pacific, Leica Biosystems
Speakers:
Dr Alexander Gosling AM, Non-Executive Director
Jane Oppenheim, Scientific and Operations Director, Ego Pharmaceuticals
Ludovic Labat, CEO, Neo-Bionica
Bridgette Engeler, Senior Lecturer, Swinburne University of Technology
Shelley Jackson, Director, Australian Medtech Manufacturing Centre (AMMC), Department of Jobs, Skills, Industry and Regions
Registration:
In-person: Members $85; Non Members $175
Online: Members $25; Non Members $45
This seminar series is delivered in partnership with AMMC – an initiative of the Victorian Government
Cancellation Policy
In-person registration:
Full refund given up to 7 days prior to the event
No refunds within 7 days of the event
Online registration:
Full refund given up to 3 days prior to the event
No refunds within 3 days of the event
Dr Ewa Douroux, Marketing Director Asia Pacific, Leica Biosystems (Facilitator)
With a PhD in molecular biology and INSEAD MBA, Dr Ewa Douroux began her corporate career in scientific communication and medical affairs in Paris, and since then her career has taken her across the globe to Australia, where she currently resides.
Currently, Ewa is the Asia Pacific Marketing Director at Leica Biosystems, one of the main Global companies in tissue Pathology. Ewa has held positions in Manufacturing, Operations, Environmental Health and Safety and product management. She has been at the inception of new product lines, transformed a manufacturing facility into an award-winner, and led initiatives to reduce the carbon footprint of her workplace.
Ewa is passionate about how business can be a force for good, especially in the areas of healthcare, sustainability, diversity and inclusion. In her spare time, Ewa mentors young professionals, is an active contributor to the life of the biotech sector, a committee member on the Australian Medtech Manufacturing Centre Industry Advisory Group and a member of the AICD.
Ewa is also the proud recipient of the BioMelbourne Network Emerging Leadership Award in 2020 and the Government of Victoria Award for Women in International Business in 2018.
Currently, Ewa is the Asia Pacific Marketing Director at Leica Biosystems, one of the main Global companies in tissue Pathology. Ewa has held positions in Manufacturing, Operations, Environmental Health and Safety and product management. She has been at the inception of new product lines, transformed a manufacturing facility into an award-winner, and led initiatives to reduce the carbon footprint of her workplace.
Ewa is passionate about how business can be a force for good, especially in the areas of healthcare, sustainability, diversity and inclusion. In her spare time, Ewa mentors young professionals, is an active contributor to the life of the biotech sector, a committee member on the Australian Medtech Manufacturing Centre Industry Advisory Group and a member of the AICD.
Ewa is also the proud recipient of the BioMelbourne Network Emerging Leadership Award in 2020 and the Government of Victoria Award for Women in International Business in 2018.
Dr Alexander Gosling AM, Non-Executive Director
Alexander has been working in the field of process and product development and related research and development for 50 years. He was a founding director of Invetech and was part of the management team that led Invetech to a public listing (as Vision Systems) and then to its acquisition by Danaher Corp for $800M.
He currently works in the area of technology commercialisation, advising universities, mentoring start-ups and sitting on Boards of early-stage companies.
Alexander is an engineer with an Honours degree from Cambridge University. He is a Fellow of the Academy of Technology and Engineering, a Fellow of the Institute of Engineers Australia, a Governor of the Warren Centre for Advanced Engineering and a Member of the Australian Institute of Company Directors. He was awarded an Honorary Doctorate in Engineering from Swinburne University and a Member of the Order of Australia for services to engineering.
He currently works in the area of technology commercialisation, advising universities, mentoring start-ups and sitting on Boards of early-stage companies.
Alexander is an engineer with an Honours degree from Cambridge University. He is a Fellow of the Academy of Technology and Engineering, a Fellow of the Institute of Engineers Australia, a Governor of the Warren Centre for Advanced Engineering and a Member of the Australian Institute of Company Directors. He was awarded an Honorary Doctorate in Engineering from Swinburne University and a Member of the Order of Australia for services to engineering.
Jane Oppenheim, Scientific and Operations Director, Ego Pharmaceuticals
Jane Oppenheim is the Scientific and Operations Director of Ego Pharmaceuticals. Jane leads a team of over 300 people in Science and Operations. As Scientific and Operations Director, Jane has developed the team to ensure Ego has an inspired group of professionals ready to take on the challenges of continuous growth through improved productivity in a continually expanding facility.
Jane has led scientific development of dermatological products at Ego for 3 decades with five product ranges being market leaders in Australia. Product ranges that are market leaders include Head Lice, Sun Protection and Therapeutic skin care. Jane has led the marketing authorisation and managing compliance with pharmaceutical regulations in 14 countries including UK, Middle East and Asia. Jane leads the quality assurance team, driving process improvement for better quality and efficiency.
Jane is enthusiastic about sustainability. Jane oversees projects to ensure that Ego Pharmaceuticals is impacting positively on the environment in which they operate. Current programs include the minimisation of both water and energy usage through a series of directed projects. It is Jane’s ambition for Ego to be Carbon Neutral by 2030.
Jane has a strong belief that Australia needs a sustainable, robust, high technology manufacturing industry. She believes in creating employment for professionals, upskilling employees so that they can grow and have job satisfaction in an industry she passionately believes adds value to society.
Jane has led scientific development of dermatological products at Ego for 3 decades with five product ranges being market leaders in Australia. Product ranges that are market leaders include Head Lice, Sun Protection and Therapeutic skin care. Jane has led the marketing authorisation and managing compliance with pharmaceutical regulations in 14 countries including UK, Middle East and Asia. Jane leads the quality assurance team, driving process improvement for better quality and efficiency.
Jane is enthusiastic about sustainability. Jane oversees projects to ensure that Ego Pharmaceuticals is impacting positively on the environment in which they operate. Current programs include the minimisation of both water and energy usage through a series of directed projects. It is Jane’s ambition for Ego to be Carbon Neutral by 2030.
Jane has a strong belief that Australia needs a sustainable, robust, high technology manufacturing industry. She believes in creating employment for professionals, upskilling employees so that they can grow and have job satisfaction in an industry she passionately believes adds value to society.
Ludovic Labat, CEO, Neo-Bionica
As a business leader, Ludovic has over 20 years’ experience in the medical device and technology industry in Europe, the US and Asia Pacific with a range of global companies including Fortive, Danaher, Siemens, Tektronix and Invetech. He has a record of proven success in bringing innovations to market to generate profitable growth in global hi-tech and medical devices markets – in roles ranging from product ideation to go-to-market strategy.
Ludovic and his family share a passion for the ocean and sailing. He enjoys dinghy racing, on his own or with his wife – they competed together in the 2015 Tasar World Championships.
Ludovic and his family share a passion for the ocean and sailing. He enjoys dinghy racing, on his own or with his wife – they competed together in the 2015 Tasar World Championships.
Bridgette Engeler, Senior Lecturer, Swinburne University of Technology
Bridgette is a professional futurist and pracademic who’s curious about post-growth innovation and designing in crisis. She teaches strategic foresight, innovation and design at Swinburne University and her work considers the (un)intended consequences of change intersecting people, technology and systems. Bridgette has collaborated on projects ranging from public participatory futures installations for Melbourne Knowledge Week and Hong Kong Business of Design Week, VR and AR wearables for people with early-onset dementia and the challenges of self-sovereign identity and digital wallets, to exploring ways to use technology and new materials to support sexual and reproductive health. Bridgette’s research focus is how a lack of prospective thinking in design contributes to an ongoing cycle connected to consumer culture and material consumption that is broadly destructive and contributing to collapse of life-critical global systems.
Shelley Jackson, Director, Australian Medtech Manufacturing Centre (AMMC), Department of Jobs, Skills, Industry and Regions
Shelley is the Director of the Australian Medtech Manufacturing Centre (AMMC), a Victorian Government initiative that is supporting the growth of medtech manufacturing in Victoria. AMMC operates within the Department of Jobs, Skills, Industry and Regions, working with government, industry and health partners to deliver targeted programs to support the growth of the sector.
Previously, Shelley held several leadership roles with the Australian Trade and Investment Commission (Austrade) in Australia and overseas, including several years leading the International Health team, promoting trade and investment in Australia’s health and medtech sectors.
Previously, Shelley held several leadership roles with the Australian Trade and Investment Commission (Austrade) in Australia and overseas, including several years leading the International Health team, promoting trade and investment in Australia’s health and medtech sectors.
